Renal denervation with a resistant arterial hypertension: the results of a five-year follow-up
- 作者: Glybochko P1, Svetankova A1, Rodionov A1, Maltseva A1, Sulimov V1, Fomin V1
-
隶属关系:
- Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)
- 期: 卷 90, 编号 9 (2018)
- 页面: 88-91
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32995
- DOI: https://doi.org/10.26442/terarkh201890988-91
- ID: 32995
如何引用文章
全文:
详细
作者简介
P Glybochko
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф., акад. РАН, ректор, директор НИИ уронефрологии и репродуктивного здоровья человека Moscow, Russia
A Svetankova
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)аспирант каф. фак. терапии №1 лечебного фак-та Moscow, Russia
A Rodionov
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доцент каф. фак. терапии №1 лечебного фак-та Moscow, Russia
A Maltseva
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)студентка международной школы «Медицина будущего» ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский университет) Moscow, Russia
V Sulimov
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф., зав. каф. фак. терапии №1 лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский университет) Moscow, Russia
V Fomin
Scientific Research Institute of Human Morphology and Reproductive Health, Department of faculty therapy number 1 of the Faculty of Medicine, Federal state autonomous educational institution of higher professional education I.M.Sechenov First Moscow State Medical University (Sechenov University)
Email: fomin_vic@mail.ru
д.м.н., проф., член-корр. РАН, проректор по научно-исследовательской и клинической работе, зав. каф. фак. терапии; ORCID 0000-0002-2682-4417 Moscow, Russia
参考
- Schlaich M, Sobotka P, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension. 2009;54:1195-201.
- Esler M.D, Krum H, Schlaich M, et al. Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension. One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial. Circulation. 2012;126:2979-82.
- Bhatt D.L, Kandzari D.E, O'Neill W.W, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-401.
- Kandzari D.E, Bhatt D.L, Brar S, et al. Predictors of blood pressure response in the Symplcity HTN-3 trial. Eur Heart J. 2015;36:219-27.
- Townsend R.R, Mahfoud F, Kandzari D.E, et al. Catheter - based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham - controlled, proof - of - concept trial. Lancet. 2017 Nov 11;390(10108):2160-70.
- Kandzari D.E, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346-55. doi: https://doi.org/10.1016/S0140-6736(18)30951-6.
- Сулимов В.А., Родионов А.В., Светанкова А.А. Ренальная денервация в лечении резистентной артериальной гипертензии: результаты одногодичного наблюдения. Рациональная фармакотерапия в кардиологии. 2015;11(3):304-8.
- Böhm M, Mancia G, Schmieder R, et al. Global SYMPLICITY Registry: 3 Year Safety and Efficacy Data Hypertension. 2017;70:A092.
- Зюбанова И.В., Мордовин В.Ф., Фальковская А.Ю., Пекарский С.Е. Изменения показателей суточного мониторирования артериального давления под влиянием ренальной денервации в течение 12-месячного наблюдения. Сибирский медицинский журнал (Томск). 2015;3:44-8.
- Мусаев А.А., Арипов М.А., Алимбаев С.А. и др. Влияние ренальной денервации на качество жизни пациентов с резистентной артериальной гипертензией. Вестник Казахского Национального медицинского университета. 2015;4:86-7.
- Glassock R.J, Winearls C. Ageing and the Glomerular Filtration Rate: Truths and Consequences. Transactions of the American Clinical and Climatological Association. Trans Amer Clin Climatol Ass. 2009;120:419-28.
- Williams B, Mancia G, et al. J Hypertens. 2018 and Eur Heart J 2018, in press.